[Thulium laser resection of prostate-tangerine technique in treatment of benign prostate hyperplasia].
OBJECTIVE
To evaluate the safety and efficacy of thulium laser resection of prostate-tangerine technique (TmLRP) in treatment of benign prostate hyperplasia (BPH).


METHODS
Thirty BPH patients, aged 74 (61-83), with a mean prostate volume of 58 ml, average international prostate symptom score (IPSS) of 19, and average maximum urinary flow (Q(max)) of 8.0 ml/s underwent TmLRP using 50 watt, 2.01 microm Tm laser. The values of hematocrit, serum sodium, potassium, and chlorine concentrations, hemoglobin, Q(max), and IPSS before and 1 and 3 months after TmLRP were compared.


RESULTS
The mean operating time was 56 minutes. No significant bleeding was found during operation. Post-operative bladder irrigation was no necessary. The urethral catheter was indwelled for 1-3 days post-operatively. There were not significant differences in values of hematocrit, serum sodium, potassium, and chlorine concentrations, and hemoglobin before and 1-3 months after the operation. One month after the operation, the Q(max) was 23.1 ml/s and IPSS was 7.9, and 3 months after the operation the was 24.7 ml/s and the IPSS was 7.1. By the end of 3-month follow-up no new cases of impotence and retrograde ejaculation had been found.


CONCLUSIONS
TmLRP is a safe and efficient procedure in treatment of BPH.
Xia
Shu-jie
SJ
Institute of Urology, Shanghai Jiaotong University, First People's Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200080, China.
Zhang
Yi-nan
YN
Lu
Jun
J
Sun
Xiao-wen
XW
Zhang
Jie
J
Zhu
Yi-yong
YY
Li
Wei-guo
WG
D000368:Aged; D000369:Aged, 80 and over; D005500:Follow-Up Studies; D006801:Humans; D053685:Laser Therapy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011468:Prostatectomy / Q000379:methods*; D011470:Prostatic Hyperplasia / Q000601:surgery*; D015203:Reproducibility of Results; D013932:Thulium; D016896:Treatment Outcome
D013932:Thulium